Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 5/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | GMNN | O75496 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | STAT6 | P42226 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1682962 | 1.00 | PNP (0.47) | PNPMAPTCYP3A4KDM4EGMNN | |
| SCHEMBL10661597 | 1.00 | PNP (0.47) | PNPMAPTCYP3A4KDM4EGMNN | |
| SCHEMBL7948406 | 1.00 | PNP (0.47) | PNPMAPTCYP3A4KDM4EGMNN | |
| SCHEMBL2185989 | 1.00 | PNP (0.47) | PNPMAPTCYP3A4KDM4EGMNN | |
| SCHEMBL8789697 | 1.00 | PNP (0.47) | PNPMAPTCYP3A4KDM4EGMNN | |
| SCHEMBL313768 | 1.00 | PNP (0.47) | PNPMAPTCYP3A4KDM4EGMNN | |
| SCHEMBL6266811 | 0.99 | PNP (0.47) | PNPMAPTCYP3A4KDM4EGMNN | |
| SCHEMBL8790893 | 0.85 | KDM4E (0.44) | PNPMAPTCYP3A4KDM4EGMNN | |
| SCHEMBL3901295 | 0.85 | KDM4E (0.44) | PNPMAPTCYP3A4KDM4EGMNN | |
| SCHEMBL10663518 | 0.80 | HIF1A (0.46) | MAPTCYP3A4KDM4EGMNNLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2408448-A2 | METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION | The Board Of Trustees Of The University Of the Leland Stanford Junior University (US) | 2012-01-25 | — | — | EP | disclosed |
| EP-2408449-A2 | METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION | The Board Of Trustees Of The University Of the Leland Stanford Junior University (US) | 2012-01-25 | — | — | EP | disclosed |
| WO-2010107739-A2 | METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2010-09-23 | — | — | WO | disclosed |
| WO-2010107742-A2 | METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2010-09-23 | — | — | WO | disclosed |
| WO-2006096769-A2 | USE OF ALPHA-GLUCOSIDASE INHIBITORS TO TREAT ALPHAVIRUS INFECTIONS | INTERMUNE, INC. (US) | 2006-09-14 | — | — | WO | disclosed |
| EP-1680137-A2 | MACROCYCLIC CARBOXYLIC ACIDS AND ACYLSULFONAMIDES AS INHIBITORS OF HCV REPLICATION | Intermune, Inc. (US) | 2006-07-19 | — | — | EP | disclosed |
| WO-2006016930-A2 | METHODS FOR TREATING HCV INFECTION | INTERMUNE, INC. (US) | 2006-02-16 | — | — | WO | disclosed |
| WO-2005067454-A2 | COMBINATION THERAPY FOR TREATING HEPATITIS C VIRUS INFECTION | VALEANT PHARMACEUTICALS NORTH AMERICA (US) | 2005-07-28 | — | — | WO | disclosed |
| WO-2005037214-A2 | MACROCYCLIC CARBOXYLIC ACIDS AND ACYLSULFONAMIDES AS INHIBITORS OF HCV REPLICATION | INTERMUNE, INC. (US) | 2005-04-28 | — | — | WO | disclosed |